The content on this site is intended for healthcare professionals only
Dr Gil Morgan from OncoAlert gives his oncology highlights from social media for the week of August 15th - 21st, 2022.
Alerts this week cover papers from Kidney Cancer, Journal of Clinical Oncology and Nature Medicine.
Dr Morgan expresses the great results of downsizing with chemo for early-stage rectal cancer. Results of CO28 trial suggest that induction chemo followed by minimally invasive surgery may offer a much-desired organ-sparing option for patients with early-stage rectal cancer.
He also reminds everybody of Jill Feldman’s discussion addressing the question ‘how are biomarkers influencing patient advocacy?’ on August 23rd with AACR.
You can watch Dr Morgan's previous roundup here
Follow Dr Morgan on twitter: @OncoAlert
Follow ecancer on twitter: @ecancer
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
The Southeast Asian Breast Cancer Symposium; background, aims and successes
OncoAlert Round Up for August 25th - 31st, 2023
OncoAlert Round Up for August 4th - 10th, 2023
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer
The use of IORT at Universitätsmedizin Mannheim hospital
Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC
